Reply to the comments on: Erlotinib in combination with bevacizumab has potential benefit in non small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
Many thanks to the researchers ’ interests on our original article [1]. They have raised some issues about our paper mainly concentrating on the accuracy of the selection process, especially for the comparison groups.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Binghao Zhao, Wenxiong Zhang Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Clinical Trials | Lung Cancer | Non-Small Cell Lung Cancer | Tarceva